Federated Hermes’s Juno Therapeutics, Inc. JUNO Stock Holding History

Federated Hermes’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-60,000	Closed	-$1.79M	–	2235
2017 Q2	$1.79M	Hold	60,000	–	–	0.01%	968
2017 Q1	$1.33M	Hold	60,000	–	–	﹤0.01%	1082
2016 Q4	$1.11M	Buy	+60,000	New	+$1.47M	﹤0.01%	1103

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Federated Hermes's JUNO Position: Q1 2018 in Review

Federated Hermes sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 36,102 shares — an estimated $1.65M sold.

Federated Hermes first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $1.65M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Federated Hermes reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Federated Hermes sold 36,102 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.65M.
Federated Hermes first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Federated Hermes's Juno Therapeutics, Inc. position peaked at $1.65M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Federated Hermes's 13F filing for Q1 2018, filed 9 May 2018.